GA, Bio-Rad Sign Collaborate
News Nov 30, 2016
Genetic Analysis (GA) and Bio-Rad Laboratories Inc have announced that they have signed an agreement in which Genetic Analysis will receive an equity investment from Bio-Rad in exchange for commercialization rights, in certain territories, for Genetic Analysis’s GA-map™ technology to detect gut dysbiosis. Terms of the agreement were not disclosed.
The patented GA-map™ technology is used as an aide in the diagnosis and management of irritable bowel syndrome and inflammatory bowel disease. Dysbiosis is a microbial imbalance or maladaptation on or inside the body and is most commonly reported as a condition in the digestive tract. It has been associated with illnesses, such as inflammatory bowel disease and other chronic diseases.
“We are delighted to be linking up with Bio-Rad, a major force for innovation in in vitro diagnostic testing,” said Ronny Hermansen, CEO of Genetic Analysis. “We believe that this collaboration will accelerate the penetration of the GA tests into routine healthcare as the importance of the microbiome in major diseases becomes increasingly recognised.”
“We welcome the opportunity to partner with Genetic Analysis,” said Norman Schwartz, Bio-Rad President and CEO. “With the GA-map technology, we can offer products to analyze the microbiome associated with gut dysbiosis, which affects the quality of life of many patients around the world and can result in serious health problems.”
Source: Story from Bio-Rad Laboratories Inc. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks' style and length guidelines.
New Rapid Test for Valley Fever Should Help Reduce Diagnosis DelaysNews
November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.READ MORE
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE
Faster, More Accurate Cancer Detection Using NanoparticlesNews
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.READ MORE